Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events. (2021)

First Author: Keeney E

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jval.2020.12.012

PubMed Identifier: 34119075

Publication URI: http://europepmc.org/abstract/MED/34119075

Type: Journal Article/Review

Volume: 24

Parent Publication: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Issue: 6

ISSN: 1098-3015